Insider Transactions in Q1 2025 at Zentalis Pharmaceuticals, Inc. (ZNTL)
Insider Transaction List (Q1 2025)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jan 02
2025
|
Mark Lackner Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
4,411
-2.25%
|
$13,233
$3.12 P/Share
|